Additionally, it may serve as a marker of low-grade systemic inflammation [20], which could be partially involved in the pathogenesis of NAFLD associated with plasma BChE levels [41]. This evidence concerns the gene BCHE and metabolic dysfunction-associated steatotic liver disease.